Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 3 , Pages 220-221, May 2006

Prostate cancer: Molecular approaches for detection and prognosis, and angiogenic therapeutic targets

Center for Prostate Cancer, Department of Urologic Surgery, University of Minnesota Comprehensive Cancer Center, Minneapolis, MN, USA

Abstract 

Molecular approaches to early detection and prognostic determination of prostate cancer aggressiveness using proteomic, genomic, and immunomic arrays, as well as systemic anti-angiogenic therapy, in those patients with high-risk prostate cancer is discussed in this special issue. Recent translational advances and clinical outcomes are discussed in this issue, which will hopefully help in the development of better, more specific treatment options for those patients with currently incurable hormone-resistant prostate cancer. Molecular tumor assessment in combination with anti-angiogenic therapies in prostate cancer has come of age.

Keywords:  Prostate cancer , Angiogenesis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1078-1439(05)00300-5

doi:10.1016/j.urolonc.2005.11.030

Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 3 , Pages 220-221, May 2006

Article Tools